Income Statement
CALCIMEDICA, INC.
CALC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - |
|
Operating Expenses
|
23.12 | 24.20 | 38.10 | 36.18 | 35.95 | 29.83 |
|
Research & Development
|
15.23 | 14.48 | 15.86 | 14.11 | 18.90 | 20.96 |
|
Selling, General & Administrative
|
7.89 | 9.73 | 22.22 | 19.10 | 17.04 | 8.87 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-23.12 | -24.20 | -38.10 | -36.18 | -35.95 | -29.83 |
|
Non-Operating Income
|
-6.44 | 10.50 | 3.72 | - | - | - |
|
Interest Income
|
- | - | - | 0.58 | 0.13 | 0.14 |
|
Interest Expense
|
- | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
0.27 | 1.01 | 0.66 | - | - | - |
|
Income Before Tax
|
-29.56 | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-29.56 | -13.70 | -34.36 | -35.61 | -35.82 | -27.53 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-23.12 | -24.20 | -38.04 | -36.18 | -35.95 | -29.83 |
|
Earnings Per Share (Basic)
|
-1.97 | -1.22 | -7.66 | -1.66 | - | - |
|
Diluted EPS
|
-1.97 | -1.22 | -7.66 | -1.66 | - | - |
|
Weighted Average Shares
|
15.01 | 11.25 | 4.49 | 21.49 | - | - |
|
Diluted Weighted Avg Shares
|
15.01 | 11.25 | 4.49 | 21.49 | - | - |
|
Comprehensive Income
|
-29.57 | -13.70 | -34.36 | -35.63 | -35.83 | -27.54 |